CoLucid Pharmaceuticals (CLCD) Priced

Late-stage biotech developing therapies for acute migraines.

Health Care - Biotechnology

IPO Performance
Latest Trade $46.50 0.00 (0.0%)
First Day Return -20.0%
Return from IPO 365.0%
 
CoLucid Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 03/30/2015
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 5.5
Deal Size ($mm) 55
 
IPO Data
IPO Date 05/05/2015
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 5.5
Deal Size ($mm) $55
 
Underwriters
more
Business Overview
Late-stage biotech developing therapies for acute migraines.
Late-stage biotech developing therapies for acute migraines.
more
Company Data
Headquarters Burlington, MA
Founded 2005
Employees 5
Website www.colucid.com
 

Performance vs. IPO Index (IPOUSA)